Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,246 | 64,216 | 36,033 | 33,997 | 36,729 |
| Marketable Securities | 59,909 | 46,520 | 98,774 | 141,841 | 152,701 |
| Receivables | 8,333 | 8,918 | 6,914 | 5,689 | 5,738 |
| Other current assets | 603 | 550 | 608 | 498 | 511 |
| TOTAL | $123,914 | $123,377 | $145,486 | $184,825 | $197,381 |
| Non-Current Assets | |||||
| PPE Net | 3,441 | 3,371 | 3,208 | 3,167 | 2,532 |
| Investments And Advances | 48,037 | 59,074 | 51,095 | 25,541 | 15,277 |
| Other Non-Current Assets | 179 | 381 | 472 | 546 | 632 |
| TOTAL | $51,657 | $62,826 | $54,775 | $29,254 | $18,441 |
| Total Assets | $175,572 | $186,203 | $200,261 | $214,079 | $215,822 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,001 | 2,996 | 2,324 | 3,648 | 2,081 |
| Accrued Expenses | 7,543 | 8,431 | 7,054 | 6,816 | 4,862 |
| Other current liabilities | 17 | 16 | N/A | 13 | N/A |
| TOTAL | $70,666 | $67,722 | $63,037 | $62,470 | $55,501 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 58,106 | 56,280 | 53,647 | 51,993 | 48,546 |
| Other Non-Current Liabilities | 39 | 44 | 0 | 42 | 0 |
| TOTAL | $15,496 | $28,183 | $40,284 | $52,035 | $60,703 |
| Total Liabilities | $86,163 | $95,906 | $103,322 | $114,505 | $116,204 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,144 | 36,050 | 35,973 | 35,926 | 35,910 |
| Common Shares | 36 | 36 | 36 | 36 | 36 |
| Retained earnings | -171,023 | -167,981 | -159,754 | -155,892 | -155,044 |
| Other shareholders' equity | 21 | -88 | 33 | 73 | 67 |
| TOTAL | $89,409 | $90,297 | $96,939 | $99,573 | $99,618 |
| Total Liabilities And Equity | $175,572 | $186,203 | $200,261 | $214,079 | $215,822 |